These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 18268197)

  • 1. Plasma beta amyloid and the risk of Alzheimer disease and dementia in elderly men: a prospective, population-based cohort study.
    Sundelöf J; Giedraitis V; Irizarry MC; Sundström J; Ingelsson E; Rönnemaa E; Arnlöv J; Gunnarsson MD; Hyman BT; Basun H; Ingelsson M; Lannfelt L; Kilander L
    Arch Neurol; 2008 Feb; 65(2):256-63. PubMed ID: 18268197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Midlife blood pressure, plasma β-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study.
    Shah NS; Vidal JS; Masaki K; Petrovitch H; Ross GW; Tilley C; DeMattos RB; Tracy RP; White LR; Launer LJ
    Hypertension; 2012 Apr; 59(4):780-6. PubMed ID: 22392902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma beta-amyloid peptide Abeta(42) levels, incident dementia, and mortality in Down syndrome.
    Schupf N; Patel B; Pang D; Zigman WB; Silverman W; Mehta PD; Mayeux R
    Arch Neurol; 2007 Jul; 64(7):1007-13. PubMed ID: 17620492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of plasma Aβ as predictor of Alzheimer's disease in older individuals without dementia: a population-based study.
    Hansson O; Stomrud E; Vanmechelen E; Östling S; Gustafson DR; Zetterberg H; Blennow K; Skoog I
    J Alzheimers Dis; 2012; 28(1):231-8. PubMed ID: 21955816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma amyloid-β levels and prognosis in incident dementia cases of the 3-City Study.
    Gabelle A; Richard F; Gutierrez LA; Schraen S; Delva F; Rouaud O; Buée L; Dartigues JF; Touchon J; Lambert JC; Berr C
    J Alzheimers Dis; 2013; 33(2):381-91. PubMed ID: 22976074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum cystatin C and the risk of Alzheimer disease in elderly men.
    Sundelöf J; Arnlöv J; Ingelsson E; Sundström J; Basu S; Zethelius B; Larsson A; Irizarry MC; Giedraitis V; Rönnemaa E; Degerman-Gunnarsson M; Hyman BT; Basun H; Kilander L; Lannfelt L
    Neurology; 2008 Sep; 71(14):1072-9. PubMed ID: 18824671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Plasma Total Tau Level as a Predictive Biomarker for Dementia and Related Endophenotypes.
    Pase MP; Beiser AS; Himali JJ; Satizabal CL; Aparicio HJ; DeCarli C; Chêne G; Dufouil C; Seshadri S
    JAMA Neurol; 2019 May; 76(5):598-606. PubMed ID: 30830207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Abeta levels as predictors of conversion to mild cognitive impairment/Alzheimer disease in an ADAPT subcohort.
    Abdullah L; Luis C; Paris D; Mouzon B; Ait-Ghezala G; Keegan AP; Wang D; Crawford F; Mullan M
    Mol Med; 2009; 15(11-12):432-7. PubMed ID: 19707525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma amyloid-β as a predictor of dementia and cognitive decline: a systematic review and meta-analysis.
    Koyama A; Okereke OI; Yang T; Blacker D; Selkoe DJ; Grodstein F
    Arch Neurol; 2012 Jul; 69(7):824-31. PubMed ID: 22451159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma amyloid-β and risk of Alzheimer's disease in the Framingham Heart Study.
    Chouraki V; Beiser A; Younkin L; Preis SR; Weinstein G; Hansson O; Skoog I; Lambert JC; Au R; Launer L; Wolf PA; Younkin S; Seshadri S
    Alzheimers Dement; 2015 Mar; 11(3):249-57.e1. PubMed ID: 25217292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study.
    Schilling S; Tzourio C; Soumaré A; Kaffashian S; Dartigues JF; Ancelin ML; Samieri C; Dufouil C; Debette S
    PLoS Med; 2017 Mar; 14(3):e1002265. PubMed ID: 28350817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma biomarkers for predicting the development of dementia in a community-dwelling older Japanese population.
    Ohara T; Tatebe H; Hata J; Honda T; Shibata M; Matsuura S; Mikami T; Maeda T; Ono K; Mimura M; Nakashima K; Iga JI; Takebayashi M; Tokuda T; Ninomiya T;
    Psychiatry Clin Neurosci; 2024 Jun; 78(6):362-371. PubMed ID: 38606661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
    Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
    J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study.
    Lopez OL; Kuller LH; Mehta PD; Becker JT; Gach HM; Sweet RA; Chang YF; Tracy R; DeKosky ST
    Neurology; 2008 May; 70(19):1664-71. PubMed ID: 18401021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.
    Mattsson N; Cullen NC; Andreasson U; Zetterberg H; Blennow K
    JAMA Neurol; 2019 Jul; 76(7):791-799. PubMed ID: 31009028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Plasma Amyloid-β and Dementia Among Black and White Older Adults.
    Jiang X; Bahorik AL; Graff-Radford NR; Yaffe K
    J Alzheimers Dis; 2024; 99(2):787-797. PubMed ID: 38701147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma amyloid β, depression, and dementia in community-dwelling elderly.
    Direk N; Schrijvers EM; de Bruijn RF; Mirza S; Hofman A; Ikram MA; Tiemeier H
    J Psychiatr Res; 2013 Apr; 47(4):479-85. PubMed ID: 23312759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma amyloid-β levels, cerebral atrophy and risk of dementia: a population-based study.
    Hilal S; Wolters FJ; Verbeek MM; Vanderstichele H; Ikram MK; Stoops E; Ikram MA; Vernooij MW
    Alzheimers Res Ther; 2018 Jun; 10(1):63. PubMed ID: 29960604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.